Expert Perspectives on Practice-Changing Advances in Induction Therapy for High-Risk AML in Older Patients

Clinical Focus - In this interactive, CME/CE-certified module, Jeffrey E. Lancet, MD, explores new approaches with induction therapy that may improve outcomes for older, high-risk patients with acute myeloid leukemia.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research